231 related articles for article (PubMed ID: 28403101)
1. Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single center.
Rong Y; Wang D; Xu C; Ji Y; Jin D; Wu W; Xu X; Kuang T; Lou W
Medicine (Baltimore); 2017 Apr; 96(15):e6599. PubMed ID: 28403101
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical meaning of histological subtypes of intraductal papillary mucinous neoplasm of the pancreas.
Kang MJ; Lee KB; Jang JY; Han IW; Kim SW
Pancreas; 2013 Aug; 42(6):959-66. PubMed ID: 23462330
[TBL] [Abstract][Full Text] [Related]
3. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of pathologic subtypes and minimal invasion in intraductal papillary mucinous neoplasms of the pancreas.
Kim J; Jang KT; Mo Park S; Lim SW; Kim JH; Lee KH; Lee JK; Heo JS; Choi SH; Choi DW; Rhee JC; Lee KT
Tumour Biol; 2011 Jun; 32(3):535-42. PubMed ID: 21190101
[TBL] [Abstract][Full Text] [Related]
5. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm.
Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Ann Surg Oncol; 2014 Jul; 21(7):2444-52. PubMed ID: 24562937
[TBL] [Abstract][Full Text] [Related]
6. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
[TBL] [Abstract][Full Text] [Related]
7. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Molin MD; Matthaei H; Wu J; Blackford A; Debeljak M; Rezaee N; Wolfgang CL; Butturini G; Salvia R; Bassi C; Goggins MG; Kinzler KW; Vogelstein B; Eshleman JR; Hruban RH; Maitra A
Ann Surg Oncol; 2013 Nov; 20(12):3802-8. PubMed ID: 23846778
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of peritumoral histological findings in subtypes of intraductal papillary mucinous neoplasms of the pancreas.
Saito M; Imada H; Suzuki T; Sata N; Yasuda Y; Maetani I; Fukushima N
Ann Diagn Pathol; 2015 Oct; 19(5):347-52. PubMed ID: 26265194
[TBL] [Abstract][Full Text] [Related]
10. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
11. Significance of aggressive surgery for an invasive carcinoma derived from an intraductal papillary mucinous neoplasm diagnosed preoperatively as borderline resectable.
Aimoto T; Mizutani S; Kawano Y; Suzuki H; Uchida E
J Nippon Med Sch; 2013; 80(5):371-7. PubMed ID: 24189355
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of the spectrum and outcomes of different histologic subtypes of noninvasive and invasive intraductal papillary mucinous neoplasms.
Koh YX; Zheng HL; Chok AY; Tan CS; Wyone W; Lim TK; Tan DM; Goh BK
Surgery; 2015 Mar; 157(3):496-509. PubMed ID: 25656693
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas.
Hibi Y; Fukushima N; Tsuchida A; Sofuni A; Itoi T; Moriyasu F; Mukai K; Aoki T
Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.
Mino-Kenudson M; Fernández-del Castillo C; Baba Y; Valsangkar NP; Liss AS; Hsu M; Correa-Gallego C; Ingkakul T; Perez Johnston R; Turner BG; Androutsopoulos V; Deshpande V; McGrath D; Sahani DV; Brugge WR; Ogino S; Pitman MB; Warshaw AL; Thayer SP
Gut; 2011 Dec; 60(12):1712-20. PubMed ID: 21508421
[TBL] [Abstract][Full Text] [Related]
15. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection.
Marchegiani G; Mino-Kenudson M; Sahora K; Morales-Oyarvide V; Thayer S; Ferrone C; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Ann Surg; 2015 May; 261(5):976-83. PubMed ID: 24979607
[TBL] [Abstract][Full Text] [Related]
16. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma.
Yopp AC; Katabi N; Janakos M; Klimstra DS; D'Angelica MI; DeMatteo RP; Fong Y; Brennan MF; Jarnagin WR; Allen PJ
Ann Surg; 2011 May; 253(5):968-74. PubMed ID: 21422912
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
18. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas.
Furukawa T; Hatori T; Fujita I; Yamamoto M; Kobayashi M; Ohike N; Morohoshi T; Egawa S; Unno M; Takao S; Osako M; Yonezawa S; Mino-Kenudson M; Lauwers GY; Yamaguchi H; Ban S; Shimizu M
Gut; 2011 Apr; 60(4):509-16. PubMed ID: 21193453
[TBL] [Abstract][Full Text] [Related]
20. Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio.
Partelli S; Fernandez-Del Castillo C; Bassi C; Mantovani W; Thayer SP; Crippa S; Ferrone CR; Falconi M; Pederzoli P; Warshaw AL; Salvia R
Ann Surg; 2010 Mar; 251(3):477-82. PubMed ID: 20142730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
